Rein Therapeutics, Inc. · NASDAQ:RNTX
Lynwood Capital Management Inc. reported a 5.00% stake in Rein Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Lynwood Capital Management Inc. reported a 5.00% stake in Rein Therapeutics, Inc., 4,280,500 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 5.00%
- Shares
- 4,280,500
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Lynwood Capital Management Inc. | 5.00% | 4,280,500 |
| Ben Shapiro | 5.00% | 4,280,500 |
| Lynwood Opportunities Master Fund | 5.00% | 4,280,500 |
Source
Related
- Rein Therapeutics, Inc.
- Lynwood Capital Management Inc.
- Rein Therapeutics, Inc. shareholders
- Schedule 13G · Lynwood Capital Management Inc. · May 8, 2026
- Schedule 13G · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Laurence W. Lytton · Aug 13, 2026
- Schedule 13G/A · Voss Capital, LP · Jul 14, 2026
- Form 4 · Von Rickenbach Josef H · May 28, 2026
- Form 4 · Windsor James Brian · May 13, 2026